Rituximab for Autoimmune Encephalitis with Epilepsy
Intractable epilepsy remains a significant medical challenge, resulting in recurrent and prolonged intensive care unit (ICU) admissions. Autoimmune encephalitis is emerging as a treatable cause of intractable epilepsy. It is characterized by antibodies against cerebral antigens, such as potassium ch...
Saved in:
Main Authors: | Mohankumar Kurukumbi, Rahul H. Dave, Jose Castillo, Tulsi Shah, Joanne Lau |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/5843089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of rituximab as second-line therapy for autoimmune encephalitis: A systematic review and meta-analysis
by: Lin-ming Zhang, et al.
Published: (2025-01-01) -
Perfusion Imaging in Autoimmune Encephalitis
by: Deepak Vallabhaneni, et al.
Published: (2018-01-01) -
Assessment of clinical prognosis in autoimmune encephalitis: Girona score
by: Gary Álvarez Bravo, et al.
Published: (2025-01-01) -
Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas
by: Claudio Fozza, et al.
Published: (2011-01-01) -
Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis
by: Cai-yun Liu, et al.
Published: (2017-01-01)